Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis by Primary Retinal Pigment Epithelial Cells Transplantation

NCT03566147 is registered in ClinicalTrials.gov with Eyecure Therapeutics Inc. as lead sponsor.

NCT NCT03566147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03566147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis by Primary Retinal Pigment Epithelial Cells Transplantation
Lead sponsor
Eyecure Therapeutics Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
August 1, 2018
Completion date
March 31, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leber congenital amaurosis, retinitis pigmentosa